2022
DOI: 10.2174/1570161120666220321141805
|View full text |Cite
|
Sign up to set email alerts
|

Contribution of STIM-Activated TRPC-ORAI Channels in Pulmonary Hypertension Induced by Chronic Sustained and Intermittent Hypoxia

Abstract: Sustained and intermittent hypoxia produces vasoconstriction, arterial remodeling, and hypertension in the lung. Stromal interaction molecule (STIM)-activated Transient Receptor Potential Channels (TRPC) and Calcium Release-Activated Calcium Channel Protein (ORAI) Channels (STOC) play a key role in the progression of pulmonary hypertension in pre-clinical models of animals submitted to sustained and intermittent hypoxia. The available evidence supports the theory that oxidative stress and hypoxic inducible fac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 132 publications
1
0
0
Order By: Relevance
“…When right HF occurs, systemic venous return is blocked, and fluid leakage in the chest increases, which leads to the occurrence of pleural effusion. This finding was consistent with the results of our study ( 16 ). OSAS is highly prevalent in patients with both HF with reduced ejection fraction and HF with preserved ejection fraction, and may contribute to the development of HF, which may reflect an important modifiable risk factor for patients with HF.…”
Section: Discussionsupporting
confidence: 94%
“…When right HF occurs, systemic venous return is blocked, and fluid leakage in the chest increases, which leads to the occurrence of pleural effusion. This finding was consistent with the results of our study ( 16 ). OSAS is highly prevalent in patients with both HF with reduced ejection fraction and HF with preserved ejection fraction, and may contribute to the development of HF, which may reflect an important modifiable risk factor for patients with HF.…”
Section: Discussionsupporting
confidence: 94%